4 ms·
Joins other studies from NYU investigating psilocybin mitigation of anxiety in advanced stage cancer patients. As well as a comprehensive survey by psychiatrist
by indescions_2018 9y ago
Joins other studies from NYU investigating psilocybin mitigation of anxiety in advanced stage cancer patients. As well as a comprehensive survey by psychiatrists at Johns Hopkins showing 84% of those who tripped describing the experience as somewhat beneficial:
Survey study of challenging experiences after ingesting psilocybin mushrooms
http://journals.sagepub.com/doi/full/10.1177/0269881116662634 http://journals.sagepub.com/doi/full/10.1177/026988111666263...
As federal dollars may face a difficult path to providing the funding for psychedelic research. This represents an enormous opportunity for privately funded as well as citizen oriented science. Indeed, MAPS, the Multidisciplinary Association for Psychedelic Studies was just gifted 111 BTC from two free thinking philanthropists as part of its Pinapple Fundraising campaign!
https://www.maps.org/ https://www.maps.org/
- agumonkey 9y agoI wonder how such drugs can make patient take different treatment options for cancer. My uncle did his best after being diagnosed with terminal cancer, at times he wanted to try things but very often he ended up rejecting ideas.
- monktastic1 9y agoJust so people know, MAPS primarily funds MDMA studies. Psilocybin funding is coming largely from the Heffter Institute.
- SolaceQuantum 9y agoAre there any studies on psilocybin mushrooms on schizophrenia-spectrum people?
- tpm 9y agoNo and most likely there won't be. It is still thought that psychedelics can trigger or worsen schizophrenia in those people - it is certainly possible, though nobody knows - and all studies will try to play it on the safe side and exclude them. Remember these are still Schedule 1 illegal drugs, so anyone trying to get them rescheduled wants to avoid controversy.